SciELO - Scientific Electronic Library Online

 
vol.33 número2Fibrilación auricular y prolongación del QT después de una dosis única de hidroxicloroquinaEfectividad cemiplimab en el cáncer de células escamosas, a propósito de un caso índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista de la OFIL

versão On-line ISSN 1699-714Xversão impressa ISSN 1131-9429

Resumo

PINILLA-RELLO, A; HUARTE-LACUNZA, R; MAGALLON-MARTINEZ, A  e  CAZORLA-PODEROSO, L. Thrombocytopenia associated with ceftaroline in combination with daptomycin: report of two cases. Rev. OFIL·ILAPHAR [online]. 2023, vol.33, n.2, pp.209-211.  Epub 04-Mar-2024. ISSN 1699-714X.  https://dx.doi.org/10.4321/s1699-714x2023000200016.

Introduction:

Drug-induced thrombocytopenia is an adverse effect whose incidence is unknown, but which can be potentially severe.

Patients and methods:

The cases of two patients with thrombocytopenia associated with ceftaroline and/or daptomycin used in association in the treatment of infective endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA) are presented.

Results:

In the two cases described, a decrease in the platelet count is shown during the combined treatment, continuing the effect despite the dose reduction and being associated with ceftaroline due to the drug/effect temporal sequence. Both cases were notified to the Pharmacovigilance Service. The causality assessment of ceftaroline using the Karch Lasagna algorithm modified by Naranjo et al. was possible in the first case and probable in the second.

Conclusions:

Given the two cases described and others collected in the literature review on the risk of thrombocytopenia associated with ceftaroline, it is necessary to carry out haematological controls, especially in patients with prolonged treatments and/or with high doses. Post-authorization studies are necessary to assess the incidence of rare adverse effects.

Palavras-chave : Thrombocytopenia; ceftaroline; daptomycin; bacterial endocarditis; methicillin-resistant Staphylococcus aureus.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )